...
首页> 外文期刊>Clinical nephrology >Kidney transplantation together with another solid organ from the same donor--a single-center progress report.
【24h】

Kidney transplantation together with another solid organ from the same donor--a single-center progress report.

机译:肾脏移植以及来自同一供体的另一个实体器官-单中心进展报告。

获取原文
获取原文并翻译 | 示例

摘要

AIM: The aim of this study was to update our center's experience with combined renal transplants. SUBJECTS AND METHODS: Between January 1987 and March 1997, 93 segmental pancreas and kidney transplants with bladder drainage and cyclosporine A-based immunosuppression were performed followed by another 40 combined pancreatoduodenal-renal transplants with enteric drainage and FK-based immunosuppression until December 1998. After a mean observation time of 87 and 13.6 months respectively, 1-year survival for patient, kidney and pancreas was 95%, 90% and 77% and 100%, 97.5% and 87.5%, respectively. Rejection and graft thrombosis were major causes of graft loss in the bladder drainage group and peripancreatitis in the enteric drainage group. From 23 December 1983, 20 patients received a combined liver-kidney transplant. RESULTS: Main indications were glomerulonephritis and viral-induced cirrhosis. 5-year survival for patients and kidneys was 70% and for liver 62%. No rejections were identified in renal transplants, suggesting a potential immunoprotective effect of the liver. Septic complications were responsible for early death and disease recurrence for late patient loss. CONCLUSIONS: From our experience with combined kidney transplants, we conclude that simultaneous transplantation of the pancreas does not adversely affect the outcome of renal transplantation and that after combined liver-kidney transplantation, the liver appears to immunologically protect the kidney.
机译:目的:本研究的目的是更新我们中心在联合肾移植方面的经验。研究对象和方法:自1987年1月至1997年3月,进行了93例经节段性胰腺和肾脏移植手术,并进行了膀胱引流和基于环孢素A的免疫抑制,随后又进行了40例联合胰十二指肠肾移植手术,并进行了肠引流和基于FK的免疫抑制,直至1998年12月。平均观察时间分别为87和13.6个月,患者,肾脏和胰腺的1年生存率分别为95%,90%和77%和100%,97.5%和87.5%。排斥反应和移植物血栓形成是膀胱引流组移植物丢失和肠内引流组胰周炎的主要原因。从1983年12月23日起,有20名患者接受了肝肾联合移植。结果:主要适应症为肾小球肾炎和病毒性肝硬化。患者和肾脏的5年生存率为70%,肝脏为62%。在肾移植中未发现排斥反应,提示肝脏具有潜在的免疫保护作用。化脓性并发症是导致早期死亡和晚期患者流失的疾病复发原因。结论:根据我们联合肾脏移植的经验,我们得出结论,胰脏同时移植不会对肾脏移植的结果产生不利影响,并且肝脏-肾脏-肾脏联合移植后,肝脏似乎在免疫学上保护了肾脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号